VIR Janet Napolitano sells $16K worth of shares
Jun 03, 2025, 4:37 AM
0.00%
What does VIR do
Vir Biotechnology is a San Francisco-based clinical-stage immunology company focusing on treatments for infectious diseases, with a pipeline targeting HDV, HBV, HIV, and other viruses. The company went public on October 11, 2019, and employs 587 full-time staff.
Janet Napolitano sold 3,200 shares of VIR on 2 June at $5.05 per share, worth a total of $16K. They now own 16,416 VIR shares, or a 16% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.